1. Home
  2. ANAB vs PLPC Comparison

ANAB vs PLPC Comparison

Compare ANAB & PLPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$62.02

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$275.71

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
PLPC
Founded
2005
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Water Sewer Pipeline Comm & Power Line Construction
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
ANAB
PLPC
Price
$62.02
$275.71
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$74.64
$275.00
AVG Volume (30 Days)
601.6K
151.1K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
0.29%
EPS Growth
91.02
N/A
EPS
N/A
7.14
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
$17.19
Revenue Next Year
$31.11
$7.28
P/E Ratio
N/A
$41.05
Revenue Growth
157.01
N/A
52 Week Low
$15.40
$130.00
52 Week High
$68.39
$305.00

Technical Indicators

Market Signals
Indicator
ANAB
PLPC
Relative Strength Index (RSI) 55.41 54.61
Support Level $43.67 $212.61
Resistance Level $67.69 $282.99
Average True Range (ATR) 4.07 15.25
MACD -0.57 2.06
Stochastic Oscillator 60.16 53.69

Price Performance

Historical Comparison
ANAB
PLPC

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. The Company's primary products support, protect, connect, terminate, and secure cables and wires. The Company provides helical solutions, connectors, fiber optic and copper splice closures, solar framing applications, and electric vehicle charging station foundations. The Company's customers include public and private energy utilities and communication companies, cable operators, contractors and subcontractors, distributors, and value-added resellers. Geographically, the company operates in four regions: PLP-USA, the Americas, EMEA, and Asia-Pacific.

Share on Social Networks: